Protagenic Therapeutics, Inc.\new (PTIX) EBITDA (2016 - 2026)
Protagenic Therapeutics, Inc.\new's EBITDA came in at -$952,935 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$1.2 million a year earlier.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) EBITDA (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Protagenic Therapeutics, Inc.\new reported EBITDA of -$3.08 million; for FY2026 (ended Mar 31, 2026), it was -$4.45 million.
- Going back by fiscal year, EBITDA was -$2.58 million in FY2025, -$5.65 million in FY2024, -$4.5 million in FY2023 and -$3.56 million in FY2022.
- The five-year range for quarterly EBITDA is -$1.44 million (fiscal Q4 2025) to -$108,830 (fiscal Q4 2026).
- Business Quant data shows PTIX's EBITDA at -$108,830 (Q4 2026), -$912,531 (Q3 2026) and -$1.1 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.82 Bn | 1,135.41 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 644.52 Bn | 564.38 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 501.88 Bn | 474.99 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 358.72 Bn | 313.10 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.27 Bn | 266.26 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.62 Bn | 241.31 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.67 Bn | 197.07 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.60 Bn | 118.24 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.36 Mn | 1.36 Mn | - | -952,935.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -952,935.00 |
| Mar 31, 2026 | 1.22 Mn |
| Dec 31, 2025 | -912,531.00 |
| Sep 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | -952,450.00 |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | -401,401.00 |
| Sep 30, 2024 | -355,374.00 |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Sep 30, 2023 | -1.40 Mn |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | -714,303.00 |
| Dec 31, 2020 | -486,117.00 |
| Sep 30, 2020 | -1.05 Mn |
| Jun 30, 2020 | -457,296.00 |
| Mar 31, 2020 | -493,295.00 |
| Dec 31, 2019 | -725,774.00 |
| Sep 30, 2019 | -189,537.00 |
API Access
Protagenic Therapeutics, Inc.\new EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();